TEMPE, Ariz., May 7, 2025 /PRNewswire/ -- Economic activity in the hospital subsector grew in April for the 20th consecutive month after contracting twice in the previous four-month period, with 35 ...

Mother’s Day 2025 is almost here! Stuck on what to get your amazing Mom? Don’t panic! I’ve rounded up 50 fantastic ...

In a press release on April 24, 2025, Debiopharm explained that AbYlink is a rapid, regio-selective bioconjugation technology designed for use in therapeutic and non-invasive diagnostic applications.

However, traditional ICP monitoring techniques typically require patients to undergo invasive surgeries to have sensors implanted, limiting their use to intensive care settings. Now, researchers at ...

Researchers at Penn State have developed a hairlike electrode that could reshape brain monitoring by offering a discreet, non ...

A Welsh business developing a potentially revolutionary way of managing diabetes has received a £2m-plus funding boost from the world’s largest research and collaboration programme.

AbYlink™ is a regio-selective bioconjugation technology ideally suited for preparing conjugates for use in therapeutic and non-invasive diagnostic applications. Oncodesign Services will use this ...

“We view this as a strong validation of our global regulatory and clinical strategy as we continue to explore broader applications for our non-invasive technology.” The study is led by Dr ...